ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 120 filers reported holding ITEOS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $4,380 | 0.0% | 400,000 | 0.0% | 0.15% | -22.3% |
Q3 2023 | $4,380 | -17.3% | 400,000 | 0.0% | 0.19% | +14.6% |
Q2 2023 | $5,296 | -2.7% | 400,000 | 0.0% | 0.16% | -49.2% |
Q1 2023 | $5,444 | -30.3% | 400,000 | 0.0% | 0.32% | -25.9% |
Q4 2022 | $7,812 | -99.9% | 400,000 | 0.0% | 0.44% | +34.2% |
Q3 2022 | $7,620,000 | -7.5% | 400,000 | 0.0% | 0.32% | -26.1% |
Q2 2022 | $8,240,000 | -36.0% | 400,000 | 0.0% | 0.44% | -18.4% |
Q1 2022 | $12,872,000 | -49.2% | 400,000 | -26.5% | 0.54% | -21.5% |
Q4 2021 | $25,331,000 | -5.6% | 544,047 | -45.3% | 0.69% | +14.3% |
Q3 2021 | $26,839,000 | +5.3% | 994,047 | 0.0% | 0.60% | +16.2% |
Q2 2021 | $25,497,000 | -31.8% | 994,047 | -9.1% | 0.52% | -21.8% |
Q1 2021 | $37,395,000 | +1.1% | 1,094,047 | 0.0% | 0.66% | -16.8% |
Q4 2020 | $37,001,000 | +37.1% | 1,094,047 | 0.0% | 0.79% | +21.2% |
Q3 2020 | $26,990,000 | – | 1,094,047 | – | 0.66% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 2,738,785 | $29,989,696 | 16.06% |
MPM BioImpact LLC | 1,745,943 | $19,118,076 | 5.10% |
Saturn V Capital Management LP | 994,756 | $10,892,578 | 4.56% |
Boxer Capital, LLC | 1,804,058 | $19,754,435 | 1.05% |
RA Capital Management | 4,417,259 | $48,368,986 | 0.95% |
683 Capital Management, LLC | 810,000 | $8,869,500 | 0.69% |
Ikarian Capital, LLC | 346,471 | $3,793,857 | 0.46% |
Ikarian Capital, LLC | 3,056 | $3,346,320 | 0.40% |
BVF INC/IL | 1,259,476 | $13,791,262 | 0.37% |
DAFNA Capital Management LLC | 98,560 | $1,079,232 | 0.34% |